switching from tirzepatide to semaglutide for weight loss Tirzepatide: A Provider's Guide Switching Semaglutide to Tirzepatide |

They may be different in color, size, shape, and non-active fillers

In a March 3, 2026 press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies specifically for making claims that implied sameness with FDA-approved products - a category-wide compliance signal every buyer should understand

Centers for Disease Control and Prevention: Physical Activity and Your Weight and Health Mozaffarian D et al

With the increasing use of Glucagon-Like Peptide-1 Receptor (GLP-1R) agonists for diabetes management and weight loss, their implications in perioperative care have gained attention

Tirzepatide is a medication that works on two natural hormones in the body, GIP and GLP-1, which help control blood sugar and appetite

Retatrutide is an experimental medication being studied for the treatment of type 2 diabetes and obesity